nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—STK10—renal vein—membranous glomerulonephritis	0.151	0.272	CbGeAlD
Sorafenib—HIPK3—nephron tubule—membranous glomerulonephritis	0.0135	0.0243	CbGeAlD
Sorafenib—TIE1—epithelium—membranous glomerulonephritis	0.0124	0.0223	CbGeAlD
Sorafenib—HIPK3—kidney—membranous glomerulonephritis	0.0119	0.0214	CbGeAlD
Sorafenib—EPHX2—nephron tubule—membranous glomerulonephritis	0.0116	0.0208	CbGeAlD
Sorafenib—FLT4—epithelium—membranous glomerulonephritis	0.0102	0.0184	CbGeAlD
Sorafenib—EPHX2—cortex of kidney—membranous glomerulonephritis	0.00989	0.0178	CbGeAlD
Sorafenib—MKNK2—nephron tubule—membranous glomerulonephritis	0.00943	0.017	CbGeAlD
Sorafenib—UGT1A9—kidney—membranous glomerulonephritis	0.00929	0.0167	CbGeAlD
Sorafenib—MKNK2—epithelium—membranous glomerulonephritis	0.00924	0.0167	CbGeAlD
Sorafenib—RET—epithelium—membranous glomerulonephritis	0.00901	0.0162	CbGeAlD
Sorafenib—FLT4—cortex of kidney—membranous glomerulonephritis	0.00892	0.0161	CbGeAlD
Sorafenib—FGFR1—cortex of kidney—membranous glomerulonephritis	0.0088	0.0159	CbGeAlD
Sorafenib—RALBP1—nephron tubule—membranous glomerulonephritis	0.00852	0.0154	CbGeAlD
Sorafenib—MAP3K7—cortex of kidney—membranous glomerulonephritis	0.00833	0.015	CbGeAlD
Sorafenib—FLT1—nephron tubule—membranous glomerulonephritis	0.0081	0.0146	CbGeAlD
Sorafenib—RET—kidney—membranous glomerulonephritis	0.00808	0.0146	CbGeAlD
Sorafenib—MKNK2—cortex of kidney—membranous glomerulonephritis	0.00807	0.0145	CbGeAlD
Sorafenib—RAF1—nephron tubule—membranous glomerulonephritis	0.00805	0.0145	CbGeAlD
Sorafenib—MKNK1—cortex of kidney—membranous glomerulonephritis	0.00797	0.0144	CbGeAlD
Sorafenib—FLT1—epithelium—membranous glomerulonephritis	0.00794	0.0143	CbGeAlD
Sorafenib—RAF1—epithelium—membranous glomerulonephritis	0.00789	0.0142	CbGeAlD
Sorafenib—RALBP1—kidney—membranous glomerulonephritis	0.00748	0.0135	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—nephron tubule—membranous glomerulonephritis	0.00747	0.0135	CbGeAlD
Sorafenib—RALBP1—cortex of kidney—membranous glomerulonephritis	0.00729	0.0131	CbGeAlD
Sorafenib—FLT1—kidney—membranous glomerulonephritis	0.00712	0.0128	CbGeAlD
Sorafenib—RAF1—kidney—membranous glomerulonephritis	0.00708	0.0128	CbGeAlD
Sorafenib—FLT1—cortex of kidney—membranous glomerulonephritis	0.00693	0.0125	CbGeAlD
Sorafenib—RAF1—cortex of kidney—membranous glomerulonephritis	0.00689	0.0124	CbGeAlD
Sorafenib—EPHB6—cortex of kidney—membranous glomerulonephritis	0.00685	0.0124	CbGeAlD
Sorafenib—KDR—nephron tubule—membranous glomerulonephritis	0.00685	0.0123	CbGeAlD
Sorafenib—STK10—kidney—membranous glomerulonephritis	0.00674	0.0121	CbGeAlD
Sorafenib—KDR—epithelium—membranous glomerulonephritis	0.00671	0.0121	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—cortex of kidney—membranous glomerulonephritis	0.00639	0.0115	CbGeAlD
Sorafenib—UGT1A1—kidney—membranous glomerulonephritis	0.00636	0.0115	CbGeAlD
Sorafenib—KIT—nephron tubule—membranous glomerulonephritis	0.00607	0.0109	CbGeAlD
Sorafenib—KDR—kidney—membranous glomerulonephritis	0.00602	0.0108	CbGeAlD
Sorafenib—Vismodegib—ALB—membranous glomerulonephritis	0.00599	1	CrCbGaD
Sorafenib—KIT—epithelium—membranous glomerulonephritis	0.00595	0.0107	CbGeAlD
Sorafenib—MAP2K5—cortex of kidney—membranous glomerulonephritis	0.00586	0.0106	CbGeAlD
Sorafenib—KDR—cortex of kidney—membranous glomerulonephritis	0.00586	0.0106	CbGeAlD
Sorafenib—PDGFRB—epithelium—membranous glomerulonephritis	0.00581	0.0105	CbGeAlD
Sorafenib—KIT—kidney—membranous glomerulonephritis	0.00533	0.00961	CbGeAlD
Sorafenib—PDGFRB—kidney—membranous glomerulonephritis	0.00521	0.00939	CbGeAlD
Sorafenib—KIT—cortex of kidney—membranous glomerulonephritis	0.00519	0.00936	CbGeAlD
Sorafenib—PDGFRB—cortex of kidney—membranous glomerulonephritis	0.00507	0.00914	CbGeAlD
Sorafenib—ABCC4—nephron tubule—membranous glomerulonephritis	0.00472	0.00851	CbGeAlD
Sorafenib—ABCC2—nephron tubule—membranous glomerulonephritis	0.00457	0.00823	CbGeAlD
Sorafenib—ABCC4—kidney—membranous glomerulonephritis	0.00415	0.00748	CbGeAlD
Sorafenib—ABCC4—cortex of kidney—membranous glomerulonephritis	0.00404	0.00728	CbGeAlD
Sorafenib—HTR2B—cortex of kidney—membranous glomerulonephritis	0.00402	0.00724	CbGeAlD
Sorafenib—ABCC2—kidney—membranous glomerulonephritis	0.00401	0.00724	CbGeAlD
Sorafenib—ABCC2—cortex of kidney—membranous glomerulonephritis	0.00391	0.00705	CbGeAlD
Sorafenib—ABCG2—nephron tubule—membranous glomerulonephritis	0.00333	0.006	CbGeAlD
Sorafenib—CYP3A5—nephron tubule—membranous glomerulonephritis	0.00309	0.00557	CbGeAlD
Sorafenib—CYP2B6—nephron tubule—membranous glomerulonephritis	0.00307	0.00554	CbGeAlD
Sorafenib—CYP2C8—kidney—membranous glomerulonephritis	0.00301	0.00543	CbGeAlD
Sorafenib—CYP3A5—kidney—membranous glomerulonephritis	0.00272	0.0049	CbGeAlD
Sorafenib—CYP2B6—kidney—membranous glomerulonephritis	0.0027	0.00487	CbGeAlD
Sorafenib—CYP3A5—cortex of kidney—membranous glomerulonephritis	0.00265	0.00477	CbGeAlD
Sorafenib—CYP3A4—kidney—membranous glomerulonephritis	0.00204	0.00368	CbGeAlD
Sorafenib—CYP2D6—kidney—membranous glomerulonephritis	0.00201	0.00362	CbGeAlD
Sorafenib—ABCB1—nephron tubule—membranous glomerulonephritis	0.00164	0.00296	CbGeAlD
Sorafenib—ABCB1—epithelium—membranous glomerulonephritis	0.00161	0.0029	CbGeAlD
Sorafenib—ABCB1—kidney—membranous glomerulonephritis	0.00144	0.0026	CbGeAlD
Sorafenib—ABCB1—cortex of kidney—membranous glomerulonephritis	0.00141	0.00253	CbGeAlD
Sorafenib—CYP3A7—Metabolism—LRP2—membranous glomerulonephritis	0.000143	0.000325	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—C3—membranous glomerulonephritis	0.000142	0.000323	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PLG—membranous glomerulonephritis	0.00014	0.000319	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DQA1—membranous glomerulonephritis	0.00014	0.000318	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000139	0.000318	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000139	0.000317	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000139	0.000315	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000138	0.000314	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000137	0.000313	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD40LG—membranous glomerulonephritis	0.000137	0.000313	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD40LG—membranous glomerulonephritis	0.000137	0.000312	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—ALB—membranous glomerulonephritis	0.000135	0.000308	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD79A—membranous glomerulonephritis	0.000135	0.000307	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000134	0.000306	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—RHOA—membranous glomerulonephritis	0.000133	0.000303	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—MMP9—membranous glomerulonephritis	0.000132	0.0003	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—RHOA—membranous glomerulonephritis	0.000131	0.000297	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000129	0.000294	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000129	0.000294	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000129	0.000293	CbGpPWpGaD
Sorafenib—KIT—Immune System—C3—membranous glomerulonephritis	0.000128	0.000291	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—C3—membranous glomerulonephritis	0.000128	0.000291	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000126	0.000288	CbGpPWpGaD
Sorafenib—CDK7—Disease—RHOA—membranous glomerulonephritis	0.000126	0.000287	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000125	0.000285	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—C3—membranous glomerulonephritis	0.000125	0.000285	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000124	0.000283	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD40LG—membranous glomerulonephritis	0.000123	0.000281	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000122	0.000278	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—C3—membranous glomerulonephritis	0.000121	0.000276	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—C3—membranous glomerulonephritis	0.000121	0.000276	CbGpPWpGaD
Sorafenib—BRAF—Disease—APOE—membranous glomerulonephritis	0.000121	0.000275	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PLG—membranous glomerulonephritis	0.000121	0.000275	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—MMP9—membranous glomerulonephritis	0.00012	0.000274	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PLG—membranous glomerulonephritis	0.000119	0.000272	CbGpPWpGaD
Sorafenib—BRAF—Disease—APOA1—membranous glomerulonephritis	0.000119	0.000272	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000119	0.000271	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—TBXAS1—membranous glomerulonephritis	0.000118	0.00027	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000117	0.000267	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000117	0.000266	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000116	0.000265	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000116	0.000265	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—TBXAS1—membranous glomerulonephritis	0.000116	0.000263	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000115	0.000263	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—C3—membranous glomerulonephritis	0.000114	0.000259	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000113	0.000257	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000111	0.000252	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DRB1—membranous glomerulonephritis	0.00011	0.000251	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD40LG—membranous glomerulonephritis	0.00011	0.00025	CbGpPWpGaD
Sorafenib—KIT—Disease—APOE—membranous glomerulonephritis	0.00011	0.00025	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—C3—membranous glomerulonephritis	0.000109	0.000249	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ABCA1—membranous glomerulonephritis	0.000109	0.000249	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ABCA1—membranous glomerulonephritis	0.000109	0.000249	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—C3—membranous glomerulonephritis	0.000109	0.000248	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PLG—membranous glomerulonephritis	0.000109	0.000248	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PLG—membranous glomerulonephritis	0.000109	0.000248	CbGpPWpGaD
Sorafenib—KIT—Disease—APOA1—membranous glomerulonephritis	0.000109	0.000247	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—C3—membranous glomerulonephritis	0.000107	0.000243	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—C3—membranous glomerulonephritis	0.000106	0.000242	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—MMP9—membranous glomerulonephritis	0.000106	0.000241	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—LRP2—membranous glomerulonephritis	0.000106	0.00024	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000105	0.000239	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APOE—membranous glomerulonephritis	0.000104	0.000237	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APOE—membranous glomerulonephritis	0.000104	0.000237	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PLG—membranous glomerulonephritis	0.000103	0.000235	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—LRP2—membranous glomerulonephritis	0.000103	0.000235	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APOA1—membranous glomerulonephritis	0.000103	0.000235	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PLG—membranous glomerulonephritis	0.000103	0.000234	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APOA1—membranous glomerulonephritis	0.000103	0.000234	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000102	0.000232	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APOE—membranous glomerulonephritis	0.000102	0.000232	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000102	0.000231	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—C3—membranous glomerulonephritis	0.000101	0.00023	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000101	0.000229	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	0.0001	0.000228	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—MMP9—membranous glomerulonephritis	9.96e-05	0.000227	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	9.95e-05	0.000227	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DRB1—membranous glomerulonephritis	9.93e-05	0.000226	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PLA2G1B—membranous glomerulonephritis	9.93e-05	0.000226	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APOE—membranous glomerulonephritis	9.92e-05	0.000226	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APOA1—membranous glomerulonephritis	9.81e-05	0.000223	CbGpPWpGaD
Sorafenib—RAF1—Immune System—C3—membranous glomerulonephritis	9.72e-05	0.000221	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APOE—membranous glomerulonephritis	9.37e-05	0.000213	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ABCA1—membranous glomerulonephritis	9.27e-05	0.000211	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PLG—membranous glomerulonephritis	9.27e-05	0.000211	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APOA1—membranous glomerulonephritis	9.26e-05	0.000211	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ABCA1—membranous glomerulonephritis	9.19e-05	0.000209	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—C3—membranous glomerulonephritis	9.18e-05	0.000209	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—C3—membranous glomerulonephritis	9.17e-05	0.000209	CbGpPWpGaD
Sorafenib—BRAF—Disease—RHOA—membranous glomerulonephritis	9.14e-05	0.000208	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—C3—membranous glomerulonephritis	9.08e-05	0.000207	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	8.99e-05	0.000205	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—MMP9—membranous glomerulonephritis	8.96e-05	0.000204	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—TBXAS1—membranous glomerulonephritis	8.95e-05	0.000204	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	8.93e-05	0.000203	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DRB1—membranous glomerulonephritis	8.85e-05	0.000202	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PLG—membranous glomerulonephritis	8.84e-05	0.000201	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—RHOA—membranous glomerulonephritis	8.83e-05	0.000201	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	8.73e-05	0.000199	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	8.6e-05	0.000196	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APOE—membranous glomerulonephritis	8.53e-05	0.000194	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	8.5e-05	0.000194	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APOE—membranous glomerulonephritis	8.45e-05	0.000192	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APOA1—membranous glomerulonephritis	8.44e-05	0.000192	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL1B—membranous glomerulonephritis	8.41e-05	0.000192	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	8.4e-05	0.000191	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APOA1—membranous glomerulonephritis	8.36e-05	0.00019	CbGpPWpGaD
Sorafenib—RAF1—Disease—APOE—membranous glomerulonephritis	8.35e-05	0.00019	CbGpPWpGaD
Sorafenib—KIT—Disease—RHOA—membranous glomerulonephritis	8.32e-05	0.000189	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PLG—membranous glomerulonephritis	8.27e-05	0.000188	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—C3—membranous glomerulonephritis	8.26e-05	0.000188	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—C3—membranous glomerulonephritis	8.26e-05	0.000188	CbGpPWpGaD
Sorafenib—RAF1—Disease—APOA1—membranous glomerulonephritis	8.26e-05	0.000188	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—TBXAS1—membranous glomerulonephritis	8.23e-05	0.000187	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	8.16e-05	0.000186	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—RHOA—membranous glomerulonephritis	8.02e-05	0.000183	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—LRP2—membranous glomerulonephritis	7.97e-05	0.000182	CbGpPWpGaD
Sorafenib—FGFR1—Disease—RHOA—membranous glomerulonephritis	7.89e-05	0.00018	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—RHOA—membranous glomerulonephritis	7.87e-05	0.000179	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—C3—membranous glomerulonephritis	7.84e-05	0.000179	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—C3—membranous glomerulonephritis	7.82e-05	0.000178	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	7.78e-05	0.000177	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—RHOA—membranous glomerulonephritis	7.71e-05	0.000175	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APOE—membranous glomerulonephritis	7.69e-05	0.000175	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APOE—membranous glomerulonephritis	7.69e-05	0.000175	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PLA2G1B—membranous glomerulonephritis	7.67e-05	0.000175	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APOA1—membranous glomerulonephritis	7.61e-05	0.000173	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APOA1—membranous glomerulonephritis	7.61e-05	0.000173	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	7.59e-05	0.000173	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL1B—membranous glomerulonephritis	7.59e-05	0.000173	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL1B—membranous glomerulonephritis	7.59e-05	0.000173	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—RHOA—membranous glomerulonephritis	7.51e-05	0.000171	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	7.5e-05	0.000171	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—RHOA—membranous glomerulonephritis	7.49e-05	0.000171	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	7.49e-05	0.000171	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—LRP2—membranous glomerulonephritis	7.33e-05	0.000167	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APOE—membranous glomerulonephritis	7.3e-05	0.000166	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APOE—membranous glomerulonephritis	7.28e-05	0.000166	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	7.27e-05	0.000166	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APOA1—membranous glomerulonephritis	7.22e-05	0.000164	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL1B—membranous glomerulonephritis	7.2e-05	0.000164	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APOA1—membranous glomerulonephritis	7.2e-05	0.000164	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—APOE—membranous glomerulonephritis	7.19e-05	0.000164	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—APOE—membranous glomerulonephritis	7.19e-05	0.000164	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL1B—membranous glomerulonephritis	7.18e-05	0.000164	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PLG—membranous glomerulonephritis	7.14e-05	0.000162	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—RHOA—membranous glomerulonephritis	7.12e-05	0.000162	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—APOA1—membranous glomerulonephritis	7.11e-05	0.000162	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—APOA1—membranous glomerulonephritis	7.11e-05	0.000162	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—RHOA—membranous glomerulonephritis	7.09e-05	0.000161	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PLA2G1B—membranous glomerulonephritis	7.06e-05	0.000161	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—C3—membranous glomerulonephritis	7.05e-05	0.00016	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	7e-05	0.000159	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—TBXAS1—membranous glomerulonephritis	6.97e-05	0.000159	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	6.96e-05	0.000158	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	6.92e-05	0.000158	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	6.84e-05	0.000156	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ABCA1—membranous glomerulonephritis	6.8e-05	0.000155	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—C3—membranous glomerulonephritis	6.72e-05	0.000153	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	6.66e-05	0.000152	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ABCA1—membranous glomerulonephritis	6.65e-05	0.000151	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APOE—membranous glomerulonephritis	6.56e-05	0.000149	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APOA1—membranous glomerulonephritis	6.49e-05	0.000148	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL1B—membranous glomerulonephritis	6.47e-05	0.000147	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—RHOA—membranous glomerulonephritis	6.47e-05	0.000147	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—RHOA—membranous glomerulonephritis	6.46e-05	0.000147	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—RHOA—membranous glomerulonephritis	6.4e-05	0.000146	CbGpPWpGaD
Sorafenib—RAF1—Disease—RHOA—membranous glomerulonephritis	6.32e-05	0.000144	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—C3—membranous glomerulonephritis	6.28e-05	0.000143	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APOE—membranous glomerulonephritis	6.26e-05	0.000142	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—LRP2—membranous glomerulonephritis	6.21e-05	0.000141	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APOA1—membranous glomerulonephritis	6.19e-05	0.000141	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—MMP9—membranous glomerulonephritis	6.12e-05	0.000139	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOE—membranous glomerulonephritis	6.1e-05	0.000139	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOE—membranous glomerulonephritis	6.05e-05	0.000138	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOA1—membranous glomerulonephritis	6.03e-05	0.000137	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	5.98e-05	0.000136	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOA1—membranous glomerulonephritis	5.98e-05	0.000136	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MMP9—membranous glomerulonephritis	5.96e-05	0.000136	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	5.94e-05	0.000135	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.91e-05	0.000135	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOE—membranous glomerulonephritis	5.85e-05	0.000133	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.84e-05	0.000133	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—RHOA—membranous glomerulonephritis	5.82e-05	0.000133	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—RHOA—membranous glomerulonephritis	5.82e-05	0.000133	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOA1—membranous glomerulonephritis	5.78e-05	0.000132	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL1B—membranous glomerulonephritis	5.77e-05	0.000131	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	5.76e-05	0.000131	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ALB—membranous glomerulonephritis	5.63e-05	0.000128	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ALB—membranous glomerulonephritis	5.63e-05	0.000128	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—RHOA—membranous glomerulonephritis	5.53e-05	0.000126	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	5.52e-05	0.000126	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—RHOA—membranous glomerulonephritis	5.51e-05	0.000126	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—C3—membranous glomerulonephritis	5.42e-05	0.000123	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	5.42e-05	0.000123	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	5.38e-05	0.000122	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ABCA1—membranous glomerulonephritis	5.14e-05	0.000117	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MMP9—membranous glomerulonephritis	5.13e-05	0.000117	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MMP9—membranous glomerulonephritis	5.08e-05	0.000116	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOE—membranous glomerulonephritis	5.05e-05	0.000115	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	5.01e-05	0.000114	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOA1—membranous glomerulonephritis	4.99e-05	0.000114	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—RHOA—membranous glomerulonephritis	4.97e-05	0.000113	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	4.79e-05	0.000109	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ALB—membranous glomerulonephritis	4.78e-05	0.000109	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—RHOA—membranous glomerulonephritis	4.74e-05	0.000108	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ALB—membranous glomerulonephritis	4.74e-05	0.000108	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ABCA1—membranous glomerulonephritis	4.73e-05	0.000108	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	4.68e-05	0.000107	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	4.63e-05	0.000105	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP9—membranous glomerulonephritis	4.62e-05	0.000105	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP9—membranous glomerulonephritis	4.62e-05	0.000105	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	4.62e-05	0.000105	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOE—membranous glomerulonephritis	4.47e-05	0.000102	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—RHOA—membranous glomerulonephritis	4.43e-05	0.000101	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOA1—membranous glomerulonephritis	4.42e-05	0.000101	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP9—membranous glomerulonephritis	4.39e-05	9.99e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP9—membranous glomerulonephritis	4.38e-05	9.97e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOE—membranous glomerulonephritis	4.37e-05	9.95e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOA1—membranous glomerulonephritis	4.32e-05	9.84e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ABCA1—membranous glomerulonephritis	4e-05	9.11e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP9—membranous glomerulonephritis	3.94e-05	8.98e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RHOA—membranous glomerulonephritis	3.82e-05	8.7e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	3.79e-05	8.62e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP9—membranous glomerulonephritis	3.76e-05	8.56e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	3.74e-05	8.52e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.52e-05	8e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ALB—membranous glomerulonephritis	3.5e-05	7.97e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ALB—membranous glomerulonephritis	3.42e-05	7.79e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOE—membranous glomerulonephritis	3.38e-05	7.69e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOA1—membranous glomerulonephritis	3.34e-05	7.61e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOE—membranous glomerulonephritis	3.3e-05	7.51e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	3.26e-05	7.42e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOE—membranous glomerulonephritis	3.11e-05	7.08e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	3.09e-05	7.03e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	3.08e-05	7.02e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOA1—membranous glomerulonephritis	3.07e-05	7e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	3.05e-05	6.94e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP9—membranous glomerulonephritis	3.03e-05	6.91e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	2.97e-05	6.75e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ALB—membranous glomerulonephritis	2.65e-05	6.03e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOE—membranous glomerulonephritis	2.63e-05	6e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOA1—membranous glomerulonephritis	2.6e-05	5.93e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ALB—membranous glomerulonephritis	2.58e-05	5.88e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ALB—membranous glomerulonephritis	2.43e-05	5.54e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	2.41e-05	5.49e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ALB—membranous glomerulonephritis	2.06e-05	4.7e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	2.03e-05	4.63e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	2.01e-05	4.57e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	1.59e-05	3.62e-05	CbGpPWpGaD
